Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

Renalytix Reports Full Year Fiscal 2023 Results

September 28, 2023
LONDON and SALT LAKE CITY, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care,
Displaying 11 - 20 of 141